Keshavpal Reddy, MD
Psychiatry · Greensboro, NCNPI 1942269766
Payments from drug & device makers
Across 857 payments — averaging $560.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$338K
- Alkermes, Inc.$60K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$29K
- Otsuka America Pharmaceutical, Inc.$23K
- Tris Pharma Inc$20K
- Vanda Pharmaceuticals Inc.$7K
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 493 | $337,780 |
| Alkermes, Inc. | 95 | $59,992 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $28,659 |
| Otsuka America Pharmaceutical, Inc. | 52 | $22,542 |
| Tris Pharma Inc | 23 | $19,511 |
| Vanda Pharmaceuticals Inc. | 8 | $7,342 |
| Neurocrine Biosciences, Inc. | 27 | $806 |
| Jazz Pharmaceuticals Inc. | 1 | $800 |
| Indivior Inc. | 17 | $366 |
| MDD US Operations, LLC | 4 | $232 |
| Validus Pharmaceuticals LLC | 2 | $231 |
| Johnson & Johnson | 12 | $212 |
| Teva Pharmaceuticals USA, Inc. | 6 | $190 |
| Axsome Therapeutics, Inc. | 4 | $187 |
| Sunovion Pharmaceuticals Inc. | 11 | $165 |
| Eisai Inc. | 8 | $151 |
| Lundbeck LLC | 7 | $148 |
| Bausch Health US, LLC | 10 | $142 |
| E.r. Squibb & Sons, L.L.C. | 5 | $123 |
| Supernus Pharmaceuticals, Inc. | 6 | $101 |
| Noven Therapeutics, LLC | 5 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Corium, LLC | 3 | $56 |
| USWM, LLC | 3 | $48 |
| Merck | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $25 |
| Almatica Pharma LLC | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
How this compares
$480,034 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Greensboro
- Gerald PlovskyGreensboro$44K
- Craig ChepkeHuntersville$4.1M
- James BarkerHickory$4.1M
- Mark ReynoldsDurham$3.2M
- Oleg TcheremissineCharlotte$2M
- Richard WeislerRaleigh$1.2M
- Dan BlazerDurham$1M
- Samantha Meltzer-BrodyChapel Hill$909K
- Andrew KrystalDurham$754K
- Brian FarahWinston Salem$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.